fluorescein-5-isothiocyanate has been researched along with vidarabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, SS; Pavletic, ZS; Wang, P | 1 |
| Aghaiipour, M; Bernard, D; David, G; Hadjati, E; Iravani, M; Shaiegan, M | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and vidarabine
| Article | Year |
|---|---|
Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Topics: Annexin A5; Apoptosis; Apoptosis Regulatory Proteins; Caenorhabditis elegans Proteins; Cell Cycle; Cell Division; Cell Line, Tumor; Coloring Agents; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Down-Regulation; Fluorescein-5-isothiocyanate; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Oligonucleotides, Antisense; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Vidarabine | 2002 |
Flow cytometric evaluation of red blood cell chimerism after bone marrow transplantation in Iranian patients: a preliminary study.
Topics: ABO Blood-Group System; Adolescent; Adult; Antibodies, Monoclonal; Antineoplastic Agents; Bone Marrow Transplantation; Child; Erythrocytes; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Iran; Male; Vidarabine | 2006 |